HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A long term survival case of advanced intrahepatic cholangiocarcinoma treated with multidisciplinary treatment].

Abstract
A 56-year-old man was admitted to our hospital for liver tumor of 7 cm in diameter, located mainly in the anterior segment. He underwent a hepatic resection of anterior and median segment of the liver in January 2002. Pathologically, the tumor was moderately differentiated intrahepatic cholangiocarcinoma (ICC) with vascular invasion. Hepatic arterial chemotherapy as a neoadjuvant therapy was performed. In December 2002, bone metastases in the 12th thoracic spine and iliac bone were found. Therefore, he received radiotherapy (total of 30 Gy) and a monthly bisphosphonate infusion. In May 2003, multiple intrahepatic recurrences were diagnosed. Transarterial chemoembolization for twice and an additional radio-frequency ablation were performed. Four months later, lung metastases were found, thus, he was administered TS-1. He has been alive with PS 0 for 4 and half years after the hepatic resection. No new intrahepatic recurrences were found and bone and lung metastases remained to be stable. Although only a hepatic resection is a useful therapy for ICC, such a multidisciplinary treatment may have an effect to improve the prognosis of patients with ICC.
AuthorsToshiro Masuda, Toru Beppu, Takatoshi Ishiko, Takao Mizumoto, Seiji Hosaka, Osamu Nakahara, Hiromitsu Hayashi, Hirohisa Okabe, Tsuyoshi Yamanaka, Kazutoshi Okabe, Hiroshi Takamori, Keiichiro Kanemitsu, Masahiko Hirota, Hideo Baba
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 33 Issue 12 Pg. 1944-6 (Nov 2006) ISSN: 0385-0684 [Print] Japan
PMID17212154 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Diphosphonates
  • Tegafur
Topics
  • Bile Duct Neoplasms (mortality, therapy)
  • Bile Ducts, Intrahepatic
  • Bone Neoplasms (secondary, therapy)
  • Catheter Ablation
  • Chemoembolization, Therapeutic
  • Cholangiocarcinoma (mortality, therapy)
  • Combined Modality Therapy
  • Diphosphonates (therapeutic use)
  • Hepatectomy
  • Humans
  • Male
  • Middle Aged
  • Neoadjuvant Therapy
  • Neoplasm Recurrence, Local
  • Tegafur (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: